Oct. 2020 | Poxel Secures EUR 6 Million in Non-Dilutive Financing Guaranteed by the French Government
Oct. 2020 | Poxel Announces Positive Results From Phase 2a NASH Trial With PXL770, an Oral First-in-Class Direct AMPK Activator
Sept. 2020 | Adocia announces Positive Topline Results of Phase 1b Study for M1Pram in People with type 1 Diabetes
Aug. 2020 | Adocia was granted a State-guaranteed loan (PGE) for EUR 7 million associated with a rescheduling of loan terms contracted with IPF Partners in 2019
Aug. 2020 | Lumeon Raises $30M in Funding to Support U.S. Growth with participation from IPF Partners
June 2020 | Poxel Announces Positive Pharmacokinetic (PK) / Pharmacodynamic (PD) Study Results for PXL770, a Direct AMPK Activator for the Treatment of NASH
